<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20060112/bs_nm/guidant_acquisition_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/nm/20060112/2006_01_12t104242_450x354_us_guidant_acquisition.j pg?x=130&y=102&sig=6E7qinm44pWAIoBNvlItmQ--" align="left" height="102" width="130" alt="Paul LaViolette, Chief Operating Officer of Boston Scientific, is seen in Chicago February 23, 2005. The ball is now in Boston Scientific Corp.'s court in the battle to woo cardiovascular device maker Guidant Corp. away from Johnson and Johnson, which sweetened its bid to acquire Guidant, analysts said on Thursday. (Frank Polich/Reuters)" border="0" /></a>Reuters - The ball is now in Boston Scientific
Corp.'s court in the battle to woo cardiovascular
device maker Guidant Corp. away from Johnson & Johnson
, which sweetened its bid to acquire Guidant, analysts
said on Thursday.</p><br clear=all>
View the entire article:
Ball in Boston Scientific's court in Guidant battle (Reuters)